ANAPLASTIC THYROID CANCER
Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CANCER trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced thyroid cancer: personalized drug cocktails tested
Disease control Not yet recruitingThis early-phase trial tests whether giving advanced thyroid cancer patients a personalized mix of already-approved drugs, chosen based on their tumor's genetic profile, is feasible and safe. Ten patients with no other treatment options will receive individualized drug combinatio…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Promising combo aims to add months for deadly thyroid cancer patients
Disease control Not yet recruitingThis study tests whether a combination of two drugs, zanzalintinib and cemiplimab, can help people with a rare and fast-growing thyroid cancer called anaplastic thyroid cancer live longer. The goal is to extend average survival by about 4 months. The trial will include 12 adults …
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC